bia 2474 experimental drug molecule fatty acid amide hydrolase faah inhibitor that caused severe adverse events |
||||||||||||||||||||||||||||||||||||||||
| navigate by keyword : bia 102474 fatty acid amide hydrolase inhibitor severe adverse event endocannabinoid anxiety parkinson neurology cns neurological death participant clinical trial anandamide toxic brain spinal toxicology pharmacology animal testing phase dose hydrogen carbon nitrogen oxygen disease drug therapy medicine medicinal pharmacy pharmaceutical pharma treatment molecule atoms chemical chemistry composition atomic model molecular rendering illustration |
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
| BIA 10-2474 experimental drug molecule. Fatty acid amide hydrolase (FAAH) inhibitor that caused severe adverse events in a clinical trial in France in 2016. 3D rendering. Atoms are represented as spheres with conventional color coding: hydrogen (white), carbon (grey), oxygen (red), nitrogen (blue |
||||||||||||||||||||||||||||||||||||||||
|
Stockphotos.ro (c) 2025. All stock photos are provided by Dreamstime and are copyrighted by their respective owners. |
||||||||||||||||||||||||||||||||||||||||
